Articles prepublished May 22, 2012
 |
|
Myocardial perfusion scintigraphy 2008 in Germany
Results of the fourth query
O. Lindner (1), W. Burchert (1, 2), F. M. Bengel (3, 4), R. Zimmermann (4, 5), J. vom Dahl (6), W. Schäfer (7), O. Schober (8), M. Schäfers (2, 8)
(1) Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Bad Oeynhausen; (2) Vorsitzender/Stellv. Vorsitzender der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin; (3) Cardiovascular Nuclear Medicine, Johns Hopkins Medical Institutions, Baltimore, USA; (4) Vorsitzender/Stellv. Vorsitzender Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie; (5) Medizinische Klinik, Klinikum Pforzheim GmbH, Pforzheim; (6) Klinik für Kardiologie, Kliniken Maria Hilf GmbH, Mönchengladbach; (7) Klinik für Nuklearmedizin, Kliniken Maria Hilf GmbH, Mönchengladbach; (8) European Institute of Molecular Imaging, Westfälische Wilhelms Universität Münster, Münster, Germany
Summary
Aim: The working group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine in cooperation with the working group Nuclear Cardiology of the German Cardiac Society herewith present the results of the 4th survey on myocardial perfusion scintigraphy (MPS) of the year 2008. Method: 310 questionnaires (191 private practices (PP), 93 hospitals (HO), 31 university hospitals (UH)) were evaluated. Results: MPS of 98947 patients were reported. 15% of them were younger than 50 y, 57% between 50 and 70 y and 28% older than 70 y. 88% [2007: 83%] of all were studied with Tc-99m perfusion tracers. The patient radiation exposure of a stress and rest protocol considering German standard recommended doses was 8.5 mSv, of a stress-only protocol 1.9 mSv. 77% [2007: 76%] of the MPS were performed in PP, 15% [2007: 15%] in HO and 8% [2007: 9%] in UH. From 2005 to 2008 there was a mild increase in the MPS numbers by 1.2% (PP +7.1%, HO –5.5%, UH –31.4%). The type of stress was pharmacological in 30% [2007: 27%]; 68% adenosine (of these 22% with exercise), 29% dipyridamole (of these 64% with exercise), and <1% dobutamine. Gated SPECT was performed in 46% [2007: 47%] of all rest and in 42% [2007: 44%] of all stress MPS. 62% [2007: 61%] of all institutions did not use perfusion scores. Conclusion: The MPS numbers from 2005 to 2008 in Germany can be regarded as stable. However, there are considerable shifts from HO and UH to PP. The well known potential of MPS considering risk stratification and functional analysis has not been tapped so far. Both gated SPECT and a quantitative perfusion analysis should be performed routinely in every patient.
Keywords
Myocardial perfusion scintigraphy, utilization statistics, utilization review, numerical data
DOI
http://dx.doi.org/10.3413/nukmed-0282You may also be interested in...
| 1. | ||
O. Lindner1, W. Burchert1, 2, F. M. Bengel3, 4 , R. Zimmermann4, 5, J. vom Dahl6, W. Schäfer7, O. Schober8, R. Kluge9, M. Schäfers2, 8 im Namen der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin und der Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung Nuklearmedizin 2008 47 4: 139-145 http://dx.doi.org/10.3413/nukmed-0158 | ||
| 2. | ||
O. Lindner (1,*), W. Burchert (1, 2,*), F. Bengel (3,*), R. Zimmermann (4, 5,*), J. vom Dahl (6,*), W. Schaefer (7,*), O. Schober (8,*), M. Schäfers (2, 8,*) Nuklearmedizin 2009 48 4: 131-137 http://dx.doi.org/10.3413/nukmed-0226 | ||
| 3. | Results of the query and current status | |
J. Kotzerke (1), L. Oehme (1), O. Lindner (2), D. Hellwig (3), Arbeitsausschuss PET der DGN Nuklearmedizin 2010 49 2: 58-64 http://dx.doi.org/10.3413/nukmed-0203 | ||
Articles prepublished May 15, 2012
|
|
Myocardial perfusion scintigraphy 2008 in Germany
Results of the fourth query
O. Lindner (1), W. Burchert (1, 2), F. M. Bengel (3, 4), R. Zimmermann (4, 5), J. vom Dahl (6), W. Schäfer (7), O. Schober (8), M. Schäfers (2, 8)
(1) Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Bad Oeynhausen; (2) Vorsitzender/Stellv. Vorsitzender der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin; (3) Cardiovascular Nuclear Medicine, Johns Hopkins Medical Institutions, Baltimore, USA; (4) Vorsitzender/Stellv. Vorsitzender Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie; (5) Medizinische Klinik, Klinikum Pforzheim GmbH, Pforzheim; (6) Klinik für Kardiologie, Kliniken Maria Hilf GmbH, Mönchengladbach; (7) Klinik für Nuklearmedizin, Kliniken Maria Hilf GmbH, Mönchengladbach; (8) European Institute of Molecular Imaging, Westfälische Wilhelms Universität Münster, Münster, Germany
Summary
Aim: The working group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine in cooperation with the working group Nuclear Cardiology of the German Cardiac Society herewith present the results of the 4th survey on myocardial perfusion scintigraphy (MPS) of the year 2008. Method: 310 questionnaires (191 private practices (PP), 93 hospitals (HO), 31 university hospitals (UH)) were evaluated. Results: MPS of 98947 patients were reported. 15% of them were younger than 50 y, 57% between 50 and 70 y and 28% older than 70 y. 88% [2007: 83%] of all were studied with Tc-99m perfusion tracers. The patient radiation exposure of a stress and rest protocol considering German standard recommended doses was 8.5 mSv, of a stress-only protocol 1.9 mSv. 77% [2007: 76%] of the MPS were performed in PP, 15% [2007: 15%] in HO and 8% [2007: 9%] in UH. From 2005 to 2008 there was a mild increase in the MPS numbers by 1.2% (PP +7.1%, HO –5.5%, UH –31.4%). The type of stress was pharmacological in 30% [2007: 27%]; 68% adenosine (of these 22% with exercise), 29% dipyridamole (of these 64% with exercise), and <1% dobutamine. Gated SPECT was performed in 46% [2007: 47%] of all rest and in 42% [2007: 44%] of all stress MPS. 62% [2007: 61%] of all institutions did not use perfusion scores. Conclusion: The MPS numbers from 2005 to 2008 in Germany can be regarded as stable. However, there are considerable shifts from HO and UH to PP. The well known potential of MPS considering risk stratification and functional analysis has not been tapped so far. Both gated SPECT and a quantitative perfusion analysis should be performed routinely in every patient.
Keywords
Myocardial perfusion scintigraphy, utilization statistics, utilization review, numerical data
DOI
http://dx.doi.org/10.3413/nukmed-0282You may also be interested in...
| 1. | ||
O. Lindner1, W. Burchert1, 2, F. M. Bengel3, 4 , R. Zimmermann4, 5, J. vom Dahl6, W. Schäfer7, O. Schober8, R. Kluge9, M. Schäfers2, 8 im Namen der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin und der Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung Nuklearmedizin 2008 47 4: 139-145 http://dx.doi.org/10.3413/nukmed-0158 | ||
| 2. | ||
O. Lindner (1,*), W. Burchert (1, 2,*), F. Bengel (3,*), R. Zimmermann (4, 5,*), J. vom Dahl (6,*), W. Schaefer (7,*), O. Schober (8,*), M. Schäfers (2, 8,*) Nuklearmedizin 2009 48 4: 131-137 http://dx.doi.org/10.3413/nukmed-0226 | ||
| 3. | Results of the query and current status | |
J. Kotzerke (1), L. Oehme (1), O. Lindner (2), D. Hellwig (3), Arbeitsausschuss PET der DGN Nuklearmedizin 2010 49 2: 58-64 http://dx.doi.org/10.3413/nukmed-0203 | ||
Articles prepublished May 11, 2012
|
|
Myocardial perfusion scintigraphy 2008 in Germany
Results of the fourth query
O. Lindner (1), W. Burchert (1, 2), F. M. Bengel (3, 4), R. Zimmermann (4, 5), J. vom Dahl (6), W. Schäfer (7), O. Schober (8), M. Schäfers (2, 8)
(1) Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Bad Oeynhausen; (2) Vorsitzender/Stellv. Vorsitzender der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin; (3) Cardiovascular Nuclear Medicine, Johns Hopkins Medical Institutions, Baltimore, USA; (4) Vorsitzender/Stellv. Vorsitzender Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie; (5) Medizinische Klinik, Klinikum Pforzheim GmbH, Pforzheim; (6) Klinik für Kardiologie, Kliniken Maria Hilf GmbH, Mönchengladbach; (7) Klinik für Nuklearmedizin, Kliniken Maria Hilf GmbH, Mönchengladbach; (8) European Institute of Molecular Imaging, Westfälische Wilhelms Universität Münster, Münster, Germany
Summary
Aim: The working group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine in cooperation with the working group Nuclear Cardiology of the German Cardiac Society herewith present the results of the 4th survey on myocardial perfusion scintigraphy (MPS) of the year 2008. Method: 310 questionnaires (191 private practices (PP), 93 hospitals (HO), 31 university hospitals (UH)) were evaluated. Results: MPS of 98947 patients were reported. 15% of them were younger than 50 y, 57% between 50 and 70 y and 28% older than 70 y. 88% [2007: 83%] of all were studied with Tc-99m perfusion tracers. The patient radiation exposure of a stress and rest protocol considering German standard recommended doses was 8.5 mSv, of a stress-only protocol 1.9 mSv. 77% [2007: 76%] of the MPS were performed in PP, 15% [2007: 15%] in HO and 8% [2007: 9%] in UH. From 2005 to 2008 there was a mild increase in the MPS numbers by 1.2% (PP +7.1%, HO –5.5%, UH –31.4%). The type of stress was pharmacological in 30% [2007: 27%]; 68% adenosine (of these 22% with exercise), 29% dipyridamole (of these 64% with exercise), and <1% dobutamine. Gated SPECT was performed in 46% [2007: 47%] of all rest and in 42% [2007: 44%] of all stress MPS. 62% [2007: 61%] of all institutions did not use perfusion scores. Conclusion: The MPS numbers from 2005 to 2008 in Germany can be regarded as stable. However, there are considerable shifts from HO and UH to PP. The well known potential of MPS considering risk stratification and functional analysis has not been tapped so far. Both gated SPECT and a quantitative perfusion analysis should be performed routinely in every patient.
Keywords
Myocardial perfusion scintigraphy, utilization statistics, utilization review, numerical data
DOI
http://dx.doi.org/10.3413/nukmed-0282You may also be interested in...
| 1. | ||
O. Lindner1, W. Burchert1, 2, F. M. Bengel3, 4 , R. Zimmermann4, 5, J. vom Dahl6, W. Schäfer7, O. Schober8, R. Kluge9, M. Schäfers2, 8 im Namen der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin und der Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung Nuklearmedizin 2008 47 4: 139-145 http://dx.doi.org/10.3413/nukmed-0158 | ||
| 2. | ||
O. Lindner (1,*), W. Burchert (1, 2,*), F. Bengel (3,*), R. Zimmermann (4, 5,*), J. vom Dahl (6,*), W. Schaefer (7,*), O. Schober (8,*), M. Schäfers (2, 8,*) Nuklearmedizin 2009 48 4: 131-137 http://dx.doi.org/10.3413/nukmed-0226 | ||
| 3. | Results of the query and current status | |
J. Kotzerke (1), L. Oehme (1), O. Lindner (2), D. Hellwig (3), Arbeitsausschuss PET der DGN Nuklearmedizin 2010 49 2: 58-64 http://dx.doi.org/10.3413/nukmed-0203 | ||
Articles prepublished May 03, 2012
|
|
Myocardial perfusion scintigraphy 2008 in Germany
Results of the fourth query
O. Lindner (1), W. Burchert (1, 2), F. M. Bengel (3, 4), R. Zimmermann (4, 5), J. vom Dahl (6), W. Schäfer (7), O. Schober (8), M. Schäfers (2, 8)
(1) Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Bad Oeynhausen; (2) Vorsitzender/Stellv. Vorsitzender der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin; (3) Cardiovascular Nuclear Medicine, Johns Hopkins Medical Institutions, Baltimore, USA; (4) Vorsitzender/Stellv. Vorsitzender Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie; (5) Medizinische Klinik, Klinikum Pforzheim GmbH, Pforzheim; (6) Klinik für Kardiologie, Kliniken Maria Hilf GmbH, Mönchengladbach; (7) Klinik für Nuklearmedizin, Kliniken Maria Hilf GmbH, Mönchengladbach; (8) European Institute of Molecular Imaging, Westfälische Wilhelms Universität Münster, Münster, Germany
Summary
Aim: The working group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine in cooperation with the working group Nuclear Cardiology of the German Cardiac Society herewith present the results of the 4th survey on myocardial perfusion scintigraphy (MPS) of the year 2008. Method: 310 questionnaires (191 private practices (PP), 93 hospitals (HO), 31 university hospitals (UH)) were evaluated. Results: MPS of 98947 patients were reported. 15% of them were younger than 50 y, 57% between 50 and 70 y and 28% older than 70 y. 88% [2007: 83%] of all were studied with Tc-99m perfusion tracers. The patient radiation exposure of a stress and rest protocol considering German standard recommended doses was 8.5 mSv, of a stress-only protocol 1.9 mSv. 77% [2007: 76%] of the MPS were performed in PP, 15% [2007: 15%] in HO and 8% [2007: 9%] in UH. From 2005 to 2008 there was a mild increase in the MPS numbers by 1.2% (PP +7.1%, HO –5.5%, UH –31.4%). The type of stress was pharmacological in 30% [2007: 27%]; 68% adenosine (of these 22% with exercise), 29% dipyridamole (of these 64% with exercise), and <1% dobutamine. Gated SPECT was performed in 46% [2007: 47%] of all rest and in 42% [2007: 44%] of all stress MPS. 62% [2007: 61%] of all institutions did not use perfusion scores. Conclusion: The MPS numbers from 2005 to 2008 in Germany can be regarded as stable. However, there are considerable shifts from HO and UH to PP. The well known potential of MPS considering risk stratification and functional analysis has not been tapped so far. Both gated SPECT and a quantitative perfusion analysis should be performed routinely in every patient.
Keywords
Myocardial perfusion scintigraphy, utilization statistics, utilization review, numerical data
DOI
http://dx.doi.org/10.3413/nukmed-0282You may also be interested in...
| 1. | ||
O. Lindner1, W. Burchert1, 2, F. M. Bengel3, 4 , R. Zimmermann4, 5, J. vom Dahl6, W. Schäfer7, O. Schober8, R. Kluge9, M. Schäfers2, 8 im Namen der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin und der Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung Nuklearmedizin 2008 47 4: 139-145 http://dx.doi.org/10.3413/nukmed-0158 | ||
| 2. | ||
O. Lindner (1,*), W. Burchert (1, 2,*), F. Bengel (3,*), R. Zimmermann (4, 5,*), J. vom Dahl (6,*), W. Schaefer (7,*), O. Schober (8,*), M. Schäfers (2, 8,*) Nuklearmedizin 2009 48 4: 131-137 http://dx.doi.org/10.3413/nukmed-0226 | ||
| 3. | Results of the query and current status | |
J. Kotzerke (1), L. Oehme (1), O. Lindner (2), D. Hellwig (3), Arbeitsausschuss PET der DGN Nuklearmedizin 2010 49 2: 58-64 http://dx.doi.org/10.3413/nukmed-0203 | ||
Articles prepublished April 25
|
|
Myocardial perfusion scintigraphy 2008 in Germany
Results of the fourth query
O. Lindner (1), W. Burchert (1, 2), F. M. Bengel (3, 4), R. Zimmermann (4, 5), J. vom Dahl (6), W. Schäfer (7), O. Schober (8), M. Schäfers (2, 8)
(1) Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Bad Oeynhausen; (2) Vorsitzender/Stellv. Vorsitzender der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin; (3) Cardiovascular Nuclear Medicine, Johns Hopkins Medical Institutions, Baltimore, USA; (4) Vorsitzender/Stellv. Vorsitzender Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie; (5) Medizinische Klinik, Klinikum Pforzheim GmbH, Pforzheim; (6) Klinik für Kardiologie, Kliniken Maria Hilf GmbH, Mönchengladbach; (7) Klinik für Nuklearmedizin, Kliniken Maria Hilf GmbH, Mönchengladbach; (8) European Institute of Molecular Imaging, Westfälische Wilhelms Universität Münster, Münster, Germany
Summary
Aim: The working group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine in cooperation with the working group Nuclear Cardiology of the German Cardiac Society herewith present the results of the 4th survey on myocardial perfusion scintigraphy (MPS) of the year 2008. Method: 310 questionnaires (191 private practices (PP), 93 hospitals (HO), 31 university hospitals (UH)) were evaluated. Results: MPS of 98947 patients were reported. 15% of them were younger than 50 y, 57% between 50 and 70 y and 28% older than 70 y. 88% [2007: 83%] of all were studied with Tc-99m perfusion tracers. The patient radiation exposure of a stress and rest protocol considering German standard recommended doses was 8.5 mSv, of a stress-only protocol 1.9 mSv. 77% [2007: 76%] of the MPS were performed in PP, 15% [2007: 15%] in HO and 8% [2007: 9%] in UH. From 2005 to 2008 there was a mild increase in the MPS numbers by 1.2% (PP +7.1%, HO –5.5%, UH –31.4%). The type of stress was pharmacological in 30% [2007: 27%]; 68% adenosine (of these 22% with exercise), 29% dipyridamole (of these 64% with exercise), and <1% dobutamine. Gated SPECT was performed in 46% [2007: 47%] of all rest and in 42% [2007: 44%] of all stress MPS. 62% [2007: 61%] of all institutions did not use perfusion scores. Conclusion: The MPS numbers from 2005 to 2008 in Germany can be regarded as stable. However, there are considerable shifts from HO and UH to PP. The well known potential of MPS considering risk stratification and functional analysis has not been tapped so far. Both gated SPECT and a quantitative perfusion analysis should be performed routinely in every patient.
Keywords
Myocardial perfusion scintigraphy, utilization statistics, utilization review, numerical data
DOI
http://dx.doi.org/10.3413/nukmed-0282You may also be interested in...
| 1. | ||
O. Lindner1, W. Burchert1, 2, F. M. Bengel3, 4 , R. Zimmermann4, 5, J. vom Dahl6, W. Schäfer7, O. Schober8, R. Kluge9, M. Schäfers2, 8 im Namen der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin und der Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung Nuklearmedizin 2008 47 4: 139-145 http://dx.doi.org/10.3413/nukmed-0158 | ||
| 2. | ||
O. Lindner (1,*), W. Burchert (1, 2,*), F. Bengel (3,*), R. Zimmermann (4, 5,*), J. vom Dahl (6,*), W. Schaefer (7,*), O. Schober (8,*), M. Schäfers (2, 8,*) Nuklearmedizin 2009 48 4: 131-137 http://dx.doi.org/10.3413/nukmed-0226 | ||
| 3. | Results of the query and current status | |
J. Kotzerke (1), L. Oehme (1), O. Lindner (2), D. Hellwig (3), Arbeitsausschuss PET der DGN Nuklearmedizin 2010 49 2: 58-64 http://dx.doi.org/10.3413/nukmed-0203 | ||
Articles prepublished April 24, 2012
|
|
Myocardial perfusion scintigraphy 2008 in Germany
Results of the fourth query
O. Lindner (1), W. Burchert (1, 2), F. M. Bengel (3, 4), R. Zimmermann (4, 5), J. vom Dahl (6), W. Schäfer (7), O. Schober (8), M. Schäfers (2, 8)
(1) Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Bad Oeynhausen; (2) Vorsitzender/Stellv. Vorsitzender der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin; (3) Cardiovascular Nuclear Medicine, Johns Hopkins Medical Institutions, Baltimore, USA; (4) Vorsitzender/Stellv. Vorsitzender Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie; (5) Medizinische Klinik, Klinikum Pforzheim GmbH, Pforzheim; (6) Klinik für Kardiologie, Kliniken Maria Hilf GmbH, Mönchengladbach; (7) Klinik für Nuklearmedizin, Kliniken Maria Hilf GmbH, Mönchengladbach; (8) European Institute of Molecular Imaging, Westfälische Wilhelms Universität Münster, Münster, Germany
Summary
Aim: The working group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine in cooperation with the working group Nuclear Cardiology of the German Cardiac Society herewith present the results of the 4th survey on myocardial perfusion scintigraphy (MPS) of the year 2008. Method: 310 questionnaires (191 private practices (PP), 93 hospitals (HO), 31 university hospitals (UH)) were evaluated. Results: MPS of 98947 patients were reported. 15% of them were younger than 50 y, 57% between 50 and 70 y and 28% older than 70 y. 88% [2007: 83%] of all were studied with Tc-99m perfusion tracers. The patient radiation exposure of a stress and rest protocol considering German standard recommended doses was 8.5 mSv, of a stress-only protocol 1.9 mSv. 77% [2007: 76%] of the MPS were performed in PP, 15% [2007: 15%] in HO and 8% [2007: 9%] in UH. From 2005 to 2008 there was a mild increase in the MPS numbers by 1.2% (PP +7.1%, HO –5.5%, UH –31.4%). The type of stress was pharmacological in 30% [2007: 27%]; 68% adenosine (of these 22% with exercise), 29% dipyridamole (of these 64% with exercise), and <1% dobutamine. Gated SPECT was performed in 46% [2007: 47%] of all rest and in 42% [2007: 44%] of all stress MPS. 62% [2007: 61%] of all institutions did not use perfusion scores. Conclusion: The MPS numbers from 2005 to 2008 in Germany can be regarded as stable. However, there are considerable shifts from HO and UH to PP. The well known potential of MPS considering risk stratification and functional analysis has not been tapped so far. Both gated SPECT and a quantitative perfusion analysis should be performed routinely in every patient.
Keywords
Myocardial perfusion scintigraphy, utilization statistics, utilization review, numerical data
DOI
http://dx.doi.org/10.3413/nukmed-0282You may also be interested in...
| 1. | ||
O. Lindner1, W. Burchert1, 2, F. M. Bengel3, 4 , R. Zimmermann4, 5, J. vom Dahl6, W. Schäfer7, O. Schober8, R. Kluge9, M. Schäfers2, 8 im Namen der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin und der Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung Nuklearmedizin 2008 47 4: 139-145 http://dx.doi.org/10.3413/nukmed-0158 | ||
| 2. | ||
O. Lindner (1,*), W. Burchert (1, 2,*), F. Bengel (3,*), R. Zimmermann (4, 5,*), J. vom Dahl (6,*), W. Schaefer (7,*), O. Schober (8,*), M. Schäfers (2, 8,*) Nuklearmedizin 2009 48 4: 131-137 http://dx.doi.org/10.3413/nukmed-0226 | ||
| 3. | Results of the query and current status | |
J. Kotzerke (1), L. Oehme (1), O. Lindner (2), D. Hellwig (3), Arbeitsausschuss PET der DGN Nuklearmedizin 2010 49 2: 58-64 http://dx.doi.org/10.3413/nukmed-0203 | ||
Articles prepublished April 12, 2012
|
|
Myocardial perfusion scintigraphy 2008 in Germany
Results of the fourth query
O. Lindner (1), W. Burchert (1, 2), F. M. Bengel (3, 4), R. Zimmermann (4, 5), J. vom Dahl (6), W. Schäfer (7), O. Schober (8), M. Schäfers (2, 8)
(1) Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Bad Oeynhausen; (2) Vorsitzender/Stellv. Vorsitzender der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin; (3) Cardiovascular Nuclear Medicine, Johns Hopkins Medical Institutions, Baltimore, USA; (4) Vorsitzender/Stellv. Vorsitzender Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie; (5) Medizinische Klinik, Klinikum Pforzheim GmbH, Pforzheim; (6) Klinik für Kardiologie, Kliniken Maria Hilf GmbH, Mönchengladbach; (7) Klinik für Nuklearmedizin, Kliniken Maria Hilf GmbH, Mönchengladbach; (8) European Institute of Molecular Imaging, Westfälische Wilhelms Universität Münster, Münster, Germany
Summary
Aim: The working group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine in cooperation with the working group Nuclear Cardiology of the German Cardiac Society herewith present the results of the 4th survey on myocardial perfusion scintigraphy (MPS) of the year 2008. Method: 310 questionnaires (191 private practices (PP), 93 hospitals (HO), 31 university hospitals (UH)) were evaluated. Results: MPS of 98947 patients were reported. 15% of them were younger than 50 y, 57% between 50 and 70 y and 28% older than 70 y. 88% [2007: 83%] of all were studied with Tc-99m perfusion tracers. The patient radiation exposure of a stress and rest protocol considering German standard recommended doses was 8.5 mSv, of a stress-only protocol 1.9 mSv. 77% [2007: 76%] of the MPS were performed in PP, 15% [2007: 15%] in HO and 8% [2007: 9%] in UH. From 2005 to 2008 there was a mild increase in the MPS numbers by 1.2% (PP +7.1%, HO –5.5%, UH –31.4%). The type of stress was pharmacological in 30% [2007: 27%]; 68% adenosine (of these 22% with exercise), 29% dipyridamole (of these 64% with exercise), and <1% dobutamine. Gated SPECT was performed in 46% [2007: 47%] of all rest and in 42% [2007: 44%] of all stress MPS. 62% [2007: 61%] of all institutions did not use perfusion scores. Conclusion: The MPS numbers from 2005 to 2008 in Germany can be regarded as stable. However, there are considerable shifts from HO and UH to PP. The well known potential of MPS considering risk stratification and functional analysis has not been tapped so far. Both gated SPECT and a quantitative perfusion analysis should be performed routinely in every patient.
Keywords
Myocardial perfusion scintigraphy, utilization statistics, utilization review, numerical data
DOI
http://dx.doi.org/10.3413/nukmed-0282You may also be interested in...
| 1. | ||
O. Lindner1, W. Burchert1, 2, F. M. Bengel3, 4 , R. Zimmermann4, 5, J. vom Dahl6, W. Schäfer7, O. Schober8, R. Kluge9, M. Schäfers2, 8 im Namen der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin und der Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung Nuklearmedizin 2008 47 4: 139-145 http://dx.doi.org/10.3413/nukmed-0158 | ||
| 2. | ||
O. Lindner (1,*), W. Burchert (1, 2,*), F. Bengel (3,*), R. Zimmermann (4, 5,*), J. vom Dahl (6,*), W. Schaefer (7,*), O. Schober (8,*), M. Schäfers (2, 8,*) Nuklearmedizin 2009 48 4: 131-137 http://dx.doi.org/10.3413/nukmed-0226 | ||
| 3. | Results of the query and current status | |
J. Kotzerke (1), L. Oehme (1), O. Lindner (2), D. Hellwig (3), Arbeitsausschuss PET der DGN Nuklearmedizin 2010 49 2: 58-64 http://dx.doi.org/10.3413/nukmed-0203 | ||
Articles prepublished April 03, 2012
|
|
Myocardial perfusion scintigraphy 2008 in Germany
Results of the fourth query
O. Lindner (1), W. Burchert (1, 2), F. M. Bengel (3, 4), R. Zimmermann (4, 5), J. vom Dahl (6), W. Schäfer (7), O. Schober (8), M. Schäfers (2, 8)
(1) Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Bad Oeynhausen; (2) Vorsitzender/Stellv. Vorsitzender der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin; (3) Cardiovascular Nuclear Medicine, Johns Hopkins Medical Institutions, Baltimore, USA; (4) Vorsitzender/Stellv. Vorsitzender Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie; (5) Medizinische Klinik, Klinikum Pforzheim GmbH, Pforzheim; (6) Klinik für Kardiologie, Kliniken Maria Hilf GmbH, Mönchengladbach; (7) Klinik für Nuklearmedizin, Kliniken Maria Hilf GmbH, Mönchengladbach; (8) European Institute of Molecular Imaging, Westfälische Wilhelms Universität Münster, Münster, Germany
Summary
Aim: The working group Cardiovascular Nuclear Medicine of the German Society of Nuclear Medicine in cooperation with the working group Nuclear Cardiology of the German Cardiac Society herewith present the results of the 4th survey on myocardial perfusion scintigraphy (MPS) of the year 2008. Method: 310 questionnaires (191 private practices (PP), 93 hospitals (HO), 31 university hospitals (UH)) were evaluated. Results: MPS of 98947 patients were reported. 15% of them were younger than 50 y, 57% between 50 and 70 y and 28% older than 70 y. 88% [2007: 83%] of all were studied with Tc-99m perfusion tracers. The patient radiation exposure of a stress and rest protocol considering German standard recommended doses was 8.5 mSv, of a stress-only protocol 1.9 mSv. 77% [2007: 76%] of the MPS were performed in PP, 15% [2007: 15%] in HO and 8% [2007: 9%] in UH. From 2005 to 2008 there was a mild increase in the MPS numbers by 1.2% (PP +7.1%, HO –5.5%, UH –31.4%). The type of stress was pharmacological in 30% [2007: 27%]; 68% adenosine (of these 22% with exercise), 29% dipyridamole (of these 64% with exercise), and <1% dobutamine. Gated SPECT was performed in 46% [2007: 47%] of all rest and in 42% [2007: 44%] of all stress MPS. 62% [2007: 61%] of all institutions did not use perfusion scores. Conclusion: The MPS numbers from 2005 to 2008 in Germany can be regarded as stable. However, there are considerable shifts from HO and UH to PP. The well known potential of MPS considering risk stratification and functional analysis has not been tapped so far. Both gated SPECT and a quantitative perfusion analysis should be performed routinely in every patient.
Keywords
Myocardial perfusion scintigraphy, utilization statistics, utilization review, numerical data
DOI
http://dx.doi.org/10.3413/nukmed-0282You may also be interested in...
| 1. | ||
O. Lindner1, W. Burchert1, 2, F. M. Bengel3, 4 , R. Zimmermann4, 5, J. vom Dahl6, W. Schäfer7, O. Schober8, R. Kluge9, M. Schäfers2, 8 im Namen der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin und der Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung Nuklearmedizin 2008 47 4: 139-145 http://dx.doi.org/10.3413/nukmed-0158 | ||
| 2. | ||
O. Lindner (1,*), W. Burchert (1, 2,*), F. Bengel (3,*), R. Zimmermann (4, 5,*), J. vom Dahl (6,*), W. Schaefer (7,*), O. Schober (8,*), M. Schäfers (2, 8,*) Nuklearmedizin 2009 48 4: 131-137 http://dx.doi.org/10.3413/nukmed-0226 | ||
| 3. | Results of the query and current status | |
J. Kotzerke (1), L. Oehme (1), O. Lindner (2), D. Hellwig (3), Arbeitsausschuss PET der DGN Nuklearmedizin 2010 49 2: 58-64 http://dx.doi.org/10.3413/nukmed-0203 | ||